Mexico Medical Device Registration – Overview
Freyr provides comprehensive regulatory consulting and lifecycle management services for medical devices in Mexico, supporting manufacturers throughout the entire regulatory process, from the definition of the initial regulatory strategy to obtaining marketing authorization and ensuring post-approval compliance.
Our services are designed to help companies navigate the Mexican regulatory framework before COFEPRIS, ensuring that medical devices comply with applicable technical, quality, and regulatory requirements prior to commercialization and throughout their entire market lifecycle. Freyr supports a broad range of medical devices, taking into account their classification, intended use, and risk profile, and adapts regulatory strategies accordingly.
By combining global regulatory standards with local regulatory expertise, Freyr Mexico assists its clients in managing regulatory submissions, maintaining regulatory compliance, and efficiently addressing regulatory changes, enabling timely market access and sustainable product lifecycle management in Mexico.
Regulatory Authority and Framework
In Mexico, medical devices are regulated by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS), the national health authority responsible for ensuring the safety, quality, and performance of health products before and after commercialization.
The regulatory framework for medical devices in Mexico is based on a risk management approach, under which regulatory requirements vary according to device classification, intended use, and the level of risk to patients and users. Compliance with applicable regulatory, technical, and quality requirements is mandatory for market access and continued commercialization.
Foreign manufacturers are required to appoint a local authorized representative or a legal entity established in Mexico to act as a regulatory liaison before COFEPRIS. This local representative is responsible for managing regulatory submissions, maintaining communication with the authority, and ensuring ongoing compliance throughout the product lifecycle.
Within this framework, regulatory oversight extends beyond the initial marketing authorization and includes post-market surveillance activities, change management, and compliance with applicable regulatory and quality obligations, reinforcing the importance of continuous regulatory management for medical devices marketed in Mexico.
Medical Device Classification in Mexico
The classification of medical devices in Mexico is established within the regulatory framework issued by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS). Devices are classified based on their intended use and potential risk to the patient or user, following risk-based classification principles aligned with international standards.
In Mexico, medical devices are divided into three classes: Class I devices are considered low-risk products; Class II devices are considered moderate-risk; while Class III devices represent the highest level of risk and are subject to more stringent regulatory controls.
There is a subclassification within Class I: low-risk Class I. This subclassification applies to products that, due to their characteristics and known use, do not require sanitary registration.
COFEPRIS Legal Representation Services
Foreign manufacturers that do not have a legal presence in Mexico must designate a Registration Holder and/or local Legal Representative to commercialize medical devices in the country.
The legal representative is responsible for submitting the registration dossier, interacting with COFEPRIS throughout the entire evaluation process, and ensuring ongoing regulatory compliance once approval has been granted.
Medical Device Registration in Mexico
Considering that in Mexico medical devices are classified under a Class I, II, and III system, aligned with international standards, the regulatory process contemplates three main pathways, whose applicability depends on device classification and the existence of prior approvals in reference markets:
Traditional pathway
Applicable when no recognized regulatory precedent exists. It involves a detailed and comprehensive technical review by COFEPRIS, with estimated evaluation timelines starting from 90 business days.
Equivalence pathway
Available for devices previously approved in the United States, Canada, or Japan. This pathway allows optimization of the evaluation process, with estimated review timelines starting from 90 business days.
Abbreviated pathway
Recently available for medical devices that hold marketing authorization in countries that are members of the Medical Device Single Audit Program (MDSAP) and the International Medical Device Regulators Forum (IMDRF). This pathway allows obtaining medical device sanitary registration in approximately 30 business days.
Post-Approval Medical Device Lifecycle Management
Post-approval change management
Administration and regulatory classification of modifications to the medical device sanitary registration, including the incorporation of new variants, accessories, changes to indications for use, or other updates that impact the authorized regulatory status, in accordance with the criteria and procedures established by COFEPRIS.
Renewal management
Support in the preparation and submission of applications related to the renewal of sanitary registration, in accordance with applicable timelines, conditions, and requirements established by COFEPRIS.
Liaison with the health authority (COFEPRIS)
Acting as a regulatory liaison between the manufacturer and COFEPRIS, facilitating communication during evaluation processes, regulatory follow-up, and post-market activities.
Importation process support
Regulatory support in managing requirements associated with the importation of medical devices registered in Mexico, in coordination with the authorities and stakeholders involved.
Medical Device Registration Summary – Mexico
Freyr Expertise
Freyr provides specialized regulatory support for medical device manufacturers seeking access to and lifecycle management of their products in the Mexican market, combining global regulatory experience with in-depth knowledge of the requirements established by COFEPRIS.
Our expertise covers the complete regulatory lifecycle of medical devices, including:
- Definition of regulatory strategy and assessment of the applicable registration pathway in Mexico
- Regulatory classification of medical devices and regulatory feasibility analysis
- Preparation, compilation, and submission of regulatory dossiers to COFEPRIS
- Support for standard and equivalence registration pathways, as applicable
- Coordination with the registration holder and local legal representative in Mexico
- Regulatory intelligence and monitoring of regulatory changes impacting medical devices
- Post-approval change management, including variations to sanitary registration
- Support in registration maintenance and compliance with administrative obligations
- Regulatory liaison with COFEPRIS during evaluation, follow-up, and post-market processes
Through a structured, risk-based approach, Freyr supports manufacturers in the timely obtainment of sanitary authorizations, continuous regulatory compliance, and the sustainable commercialization of medical devices in the Mexican market.
Technovigilance (Post-marketing surveillance)
Technovigilance plays a key role in the post-market oversight of medical devices, supporting the early detection of potential risks, enabling timely corrective actions, and ensuring the continued safety, performance, and regulatory compliance of devices marketed in Mexico.
In Mexico, technovigilance activities are regulated by the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS). These activities include, among others:
- Collection, analysis, and reporting of complaints, incidents, and adverse events related to medical devices.
- Management and reporting of health alerts and Field Safety Corrective Actions (FSCA).
- Preparation and notification of technovigilance
Companies must have a technovigilance unit constituted, and all technovigilance activities must be overseen by a local person responsible for technovigilance, duly appointed in accordance with COFEPRIS requirements.